Magnim is committed to providing our customers with high quality pharmaceuticals and nutraceuticals. Our products are designed and developed at R&D labs are meant to be manufactured in state-of-the-art, regulatory approved facilities using quality assurance techniques that meet regulatory standards. We ensure the safe and effective delivery of our products to the public.

Magnim is a knowledge driven Contract Research and Development Organization with a complete end-to-end technology platform to suite innovative dosage form development. We are dedicated to investing in Research & Development and have seasoned and extensive team of scientists developing innovative products. We are focussed on Novel Drug Delivery Systems of new active pharmaceutical ingredients including High potent & Oncology segment and development of new formulations for existing drugs under product life cycle management, addressing the patient needs through 505b(2) programs.

Ethics & Integrity

• To be ethical, honest and transparent in all that we do.

Excellence

• To commit ourselves to the highest levels of scientific and operational excellence.

Professionalism

• To practise the highest degree of professionalism by fostering individual accountability, reliability, continuous improvement and customer centricity.